Also trades as: EIGRQ (OTC) · $vol 0M
EIGR NASDAQ
Eiger BioPharmaceuticals, Inc.
1W: -35.7%
1M: +0.0%
3M: -70.0%
1Y: -95.0%
3Y: -99.3%
5Y: -99.5%
$1.73
Last traded 2025-06-17 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$16M
Revenue
+17.0% YoY
$-75M
Net Income
+23.1% YoY
$-75M
Free Cash Flow
+10.3% YoY
97.3%
Gross Margin
-331.7%
Op. Margin
-353.8%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-367.0%
ROA-94.3%
ROIC-4345.7%
Valuation
P/E-0.0
P/B-0.2
EV/EBITDA-0.4
Leverage
Debt/Equity-2.85
Current Ratio0.71
Interest Cov.-12.7x
Quality Scores
Piotroski F3/9
Altman Z-24.33
Beneish M-3.16